Showing results (1-10 of 284) with videos related to

Sort By:
Pageof 29
Cancer Treatment and Research|November 30, 2022
Rituximab-Associated Progressive Multifocal Leukoencephalopathy: A Twenty-Year UpdateCharles L Bennett, Bartlett Witherspoon, Kenneth R Carson
Cancer Treatment and Research|November 30, 2022
Was There Something Rotten in Denmark: Nephrogenic System Fibrosis Cases Occurring in CopenhagenCharles L Bennett, Bartlett Witherspoon, Kenneth R Carson, et al.
Cancer Treatment and Research|November 30, 2022
Biosimilar Epoetin in the United States: A View from the Southern Network on Adverse ReactionsSumimasa Nagai, Bartlett Witherspoon, Chadi Nabhan, et al.
Cancer Treatment and Research|November 30, 2022
Fluoroquinolone-Associated Disability and Other Fluoroquinolone-Associated Serious Adverse Events: Unexpected Toxicities Have Emerged in Recent YearsCharles L Bennett, Oscar Champigneulle, Andrew Bennett, et al.
Best Practice & Research. Clinical Haematology|March 29, 2005
Clinical characteristics of erythropoietin-associated pure red cell aplasiaKenneth R Carson, Andrew M Evens, Charles L Bennett, et al.
The American Journal of Managed Care|April 11, 2024
Adjusting starting points for initial price offers: the example of ibrutinibJason B Gibbons, Charles L Bennett, Kenneth R Carson, et al.
American Journal of Hematology|February 12, 2025
Ferric Carboxymaltose (FCM)-Associated Hypophosphatemia (HPP): A Systematic ReviewJoseph Magagnoli, Kevin Knopf, William J Hrushesky, et al.
Expert Opinion on Drug Safety|September 24, 2015
Risk-adapted strategies for the treatment of Hodgkin lymphomaJesse Keller, Kenneth R Carson
Expert Opinion on Drug Safety|May 14, 2014
A drug safety evaluation of rituximab and risk of hepatitis BPeter Riedell, Kenneth R Carson
Pageof 29